The FDA Denial

Johnson Foods spent millions trying to convince the FDA that kratom could be sold as a “dietary supplement.” The agency flatly rejected their application, citing inadequate safety data and failure to establish identity. Yet kratom advocates still cite these very documents as proof of safety – a deliberate deception.

Read the Rejection Evidence Hub
⚠️ Industry spin: They wave these PDFs as “proof the FDA reviewed kratom.” In reality, the FDA rejected the application. Return to Evidence →

The Two Documents That Expose the Industry

⛔ The NDI Submission – Their Own Application

Johnson Foods formally asked the FDA to recognize kratom as a New Dietary Ingredient. In doing so, they admitted that kratom was not marketed in the U.S. before 1994 – meaning it cannot be sold legally without FDA approval. Their proposal: a tiny 50 mg/day serving with forced “15 days on, 15 days off” – an implicit admission that daily use is dangerous.

  • They identified the ingredient as dried Mitragyna speciosa leaf powder (“kratom”).
  • They conceded it is an NDI (not grandfathered).
  • They proposed an absurdly low serving size and mandatory breaks – proof they knew continuous use posed risks.

⛔ The FDA Denial Letter – The Government’s Rejection

On January 4, 2023, the FDA told Johnson Foods: your submission is insufficient. The agency could not establish the identity of the ingredient, let alone its safety. They warned that any product containing this NDI may be considered adulterated under federal law.

  • FDA confirmed receipt of the NDI on Oct 21, 2022, and reviewed the proposed use.
  • They explicitly stated they could not establish identity or safety.
  • They warned that the product may be adulterated – a serious legal jeopardy for sellers.
🚨 What advocates won’t tell you: They wave these PDFs as “proof the FDA reviewed kratom.” In reality, the FDA rejected the application. This is not a green light – it’s a stop sign.
Open FDA Denial Letter (PDF) Open NDI Submission (PDF)

⚠️ These PDFs are the smoking gun. The industry tried to get kratom approved through the front door – and the FDA slammed it shut. Yet they still sell it through the back door, in gas stations, with no oversight.

Why This Denial Destroys the Industry's Defense

The “dietary supplement” excuse is dead

The kratom industry has long claimed that their products are legal dietary supplements. But Johnson Foods’ own NDI submission admits that kratom was not sold in the U.S. before October 15, 1994 – the cutoff for grandfathered status. That means every kratom product on the market today is, by law, a new dietary ingredient that requires FDA approval. And when one company actually sought that approval, the FDA said NO.

⛔ Identity? Unknown

FDA said it could not even establish what the ingredient is from the information provided. If the regulator can't identify it, how can any consumer know what they're swallowing?

⛔ Safety? Not Established

FDA listed specific concerns: addiction, withdrawal, neurotoxicity, drug interactions, and even death. The industry had a chance to prove safety – and failed.

⛔ Legal Status: Adulterated

FDA explicitly warned that products containing this NDI may be considered adulterated. Any state attorney general can now use this letter to seize products and file charges.

What this means for a retail ban
  • The “dietary supplement” pathway is closed. The only legal route for kratom would be as an FDA‑approved drug – which requires years of clinical trials proving safety and efficacy. That hasn’t happened.
  • It gives states the evidence they need. If the federal regulator cannot find a basis for safety, states have a duty to protect their citizens. The denial letter is a powerful tool for legislators pushing for bans.
  • It exposes the industry’s deception. For years, kratom sellers have claimed their products are “safe” and “regulated.” This letter proves otherwise. They knew the FDA had rejected their own application, yet they continued to sell.

📢 The industry’s talking points, fact‑checked

Industry lie: “The FDA just wanted more paperwork.”
Truth: The FDA said it could not even identify the ingredient – a fundamental failure that no amount of paperwork can fix without starting over.

Industry lie: “This was just one company’s application.”
Truth: Johnson Foods is a major industry player. Their failure sets a precedent: if they can’t meet the safety bar, no one can.

Industry lie: “Kratom is a traditional herb, so it’s exempt.”
Truth: Their own submission admits it was not marketed in the U.S. before 1994. No grandfather clause applies.

← Back to Evidence Open Rejection Letter

← Back to Evidence Hub | Industry Narratives